Clinical Trials Directory

Trials / Completed

CompletedNCT05846906

Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness

Oral Sildenafil Citrate: a Potential Approach for Improvement of Endometrial Thickness and Treatment of Unexplained Infertility in Women

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

One hundred thirty women with unexplained infertility participated in a prospective clinical study. Patients were assigned at random to one of two groups. The first group (n=65) served as the study group and was given clomiphene citrate 50 mg (Tecnovula®, Techno Pharmaceuticals, Egypt) and sildenafil (Respatio®, Pharma right group, Egypt) 20 mg tablets. The second group (n=65) served as a control and received a placebo tablet in addition to the standard treatment of clomiphene citrate 50 mg (Tecnovula®). A transvaginal ultrasound was performed on all of the patients to assess ovulation.

Detailed description

One hundred thirty women with unexplained infertility participated in a prospective clinical study. Patients were assigned at random to one of two groups. The first group (n=65) served as the study group and was given clomiphene citrate 50 mg (Tecnovula®, Techno Pharmaceuticals, Egypt) orally twice daily from the second day of their cycle through the seventh day and sildenafil (Respatio®, Pharma right group, Egypt) 20 mg tablets from the end of menstruation through ovulation. The second group (n=65) served as a control and received a placebo tablet in addition to the standard treatment of clomiphene citrate 50 mg (Tecnovula®). A transvaginal ultrasound was performed on all of the patients to assess ovulation, follicle count, and pregnancy. Consequences, including miscarriage, ectopic pregnancy, and multiple pregnancies, were monitored.

Conditions

Interventions

TypeNameDescription
DRUGSildenafil Citrateoral sildenafil (Respatio® 20mg )
DRUGClomiphene Citrate 50mgused for ovionulation induct

Timeline

Start date
2021-10-01
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2023-05-06
Last updated
2023-05-30

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05846906. Inclusion in this directory is not an endorsement.